EP2881111 - IMMUNE CELL ACTIVATION INHIBITOR AND USE THEREOF [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 21.07.2017 Database last updated on 18.10.2024 | |
Former | Examination is in progress Status updated on 14.04.2017 | Most recent event Tooltip | 21.07.2017 | Withdrawal of application | published on 23.08.2017 [2017/34] | Applicant(s) | For all designated states Ehime University 10-13, Dogohimata Matsuyama-shi Ehime 790-8577 / JP | [2015/24] | Inventor(s) | 01 /
TANAKA, Junya c/o Ehime University Graduate School of Medicine Shitsukawa Toon-shi Ehime 791-0295 / JP | [2015/24] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
Former [2015/24] | Tuxworth, Pamela M. J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 13826292.8 | 02.08.2013 | WO2013JP71028 | Priority number, date | JP20120173405 | 03.08.2012 Original published format: JP 2012173405 | [2015/24] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014021455 | Date: | 06.02.2014 | Language: | JA | [2014/06] | Type: | A1 Application with search report | No.: | EP2881111 | Date: | 10.06.2015 | Language: | EN | [2015/24] | Search report(s) | International search report - published on: | JP | 06.02.2014 | (Supplementary) European search report - dispatched on: | EP | 18.11.2015 | Classification | IPC: | A61K31/17, A61P25/00, A61P25/16, A61P25/28, A61P29/00, A61P31/04, A61P37/06 | [2015/24] | CPC: |
A61K31/17 (EP,US);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/04 (EP);
A61P17/06 (EP);
A61P17/08 (EP);
A61P25/00 (EP);
A61P25/16 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P31/04 (EP);
A61P37/06 (EP);
A61P37/08 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/24] | Title | German: | IMMUNZELLENAKTIVIERUNGSHEMMER UND SEINE VERWENDUNG | [2015/24] | English: | IMMUNE CELL ACTIVATION INHIBITOR AND USE THEREOF | [2015/24] | French: | INHIBITEUR DE L'ACTIVATION D'UNE CELLULE IMMUNITAIRE ET SON UTILISATION | [2015/24] | Entry into regional phase | 03.03.2015 | Translation filed | 03.03.2015 | National basic fee paid | 03.03.2015 | Search fee paid | 03.03.2015 | Designation fee(s) paid | 03.03.2015 | Examination fee paid | Examination procedure | 29.01.2014 | Request for preliminary examination filed International Preliminary Examining Authority: JP | 03.03.2015 | Examination requested [2015/24] | 06.06.2016 | Amendment by applicant (claims and/or description) | 13.04.2017 | Despatch of a communication from the examining division (Time limit: M04) | 19.07.2017 | Application withdrawn by applicant [2017/34] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 13.04.2017 | Fees paid | Renewal fee | 10.08.2015 | Renewal fee patent year 03 | 11.08.2016 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]JP2004231546 (TAISHO PHARMA CO LTD) [X] 1,8,12,13 * abstract * * paragraph [0010] * * paragraph [0012] *; | [X]JP4787499B (KOWA CO) [X] 1,8,12,13 * examples 3,8 *; | [X]US5409709 (OZAWA KIYOTAKA [JP], et al) [X] 1,8,12,13 * abstract *; | [X]UA61135 (INST PHARM & TOXICOLOGY AMMS [UA]) [X] 12,13 * abstract *; | [E]EP2702989 (KOWA CO [JP]) [E] 8 * abstract * | [XI] - CHUN-YA KUO ET AL, "Psychosis associated with bromvalerylurea abuse in a patient with traumatic brain injury", GENERAL HOSPITAL PSYCHIATRY., US, (20120501), vol. 34, no. 3, doi:10.1016/j.genhosppsych.2011.10.010, ISSN 0163-8343, pages e3 - e4, XP055227682 [X] 8 * the whole document * [I] 12,13,15 DOI: http://dx.doi.org/10.1016/j.genhosppsych.2011.10.010 | [I] - JIUN-NONG LIN ET AL, "Myoclonic jerks due to acute bromovalerylurea intoxication", CLINICAL TOXICOLOGY, US, (20080101), vol. 46, no. 9, doi:10.1080/15563650802020361, ISSN 1556-3650, pages 861 - 863, XP055227742 [I] 12-15 * the whole document * DOI: http://dx.doi.org/10.1080/15563650802020361 | International search | [X]JPH11139971 (SANKYO CO); | [Y]WO03077832 (PHARMOS CORP [US], et al); | [A]WO2009001356 (YISSUM RES DEV CO [IL], et al); | [XP] - TASUKU NISHIHARA ET AL., "Bromovalerylurea wa Macrophage no Kasseika o Yokusei shi, Haiketsusho ni Taisuru Chiryo Koka o Motsu", JOURNAL OF THE PHYSIOLOGICAL SOCIETY OF JAPAN 0031-9015, (201303), vol. 75, no. 2, page 74, XP008176656 | [XP] - HITOMI AONO ET AL., "Kotenteki na Chinsei Saimin'yaku Bromovalerylurea no Parkinson-byo Chiryoyaku to shite no Kanosei", JOURNAL OF THE PHYSIOLOGICAL SOCIETY OF JAPAN 0031-9015, (201303), vol. 75, no. 2, page 73, XP008176657 | by applicant | - HIDEKI MOCHIZUKI, "Rinsho Shinkei-gaku", PARKINSON BYOU NO CHIRYOU TO BYOUTAI, (2010), vol. 50, pages 623 - 627 | - KUMAR, A. ET AL., "A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study", CRITICAL CARE MEDICINE, (2011), vol. 38, pages 1651 - 1664 | - PIERACCI, F. M.; BARIE, P. S., "Management of severe sepsis of abdominal origin", SCANDINAVIAN JOURNAL OF SURGERY, (2007), vol. 96, pages 184 - 196 | - BALLARD, C ET AL., ALZHEIMER'S DISEASE. LANCET, (2011), vol. 377, pages 1019 - 1031 | - CHOUDHURY ET AL., BRAIN AND BEHAVIOR, (2011), vol. 1, pages 26 - 43 | - MATSUMOTO ET AL., JOURNAL OF CEREBRAL BLOOD FLOW & METABOLISM, (2008), vol. 28, pages 149 - 163 |